Research Keyword: mortality risk

Fungal Pneumonia and Severe Neutropenia: Risk Factors for Increased 90 Day Mortality

mycolabadmin

This study examined 39 cancer patients with severe fungal lung infections treated at a major cancer center. Patients who received antifungal treatment within 7 days and started with a specific drug called liposomal amphotericin B had better survival rates at 90 days. The research suggests that quick diagnosis and prompt treatment initiation are critical for improving survival in immunocompromised patients with fungal pneumonia.

Read More »

Association of mushroom consumption with all-cause and cause-specific mortality among American adults: prospective cohort study findings from NHANES III

mycolabadmin

This study followed over 15,000 American adults for nearly 20 years and found that people who ate mushrooms had a lower risk of dying from any cause compared to those who didn’t eat mushrooms. The more mushrooms people ate, the greater the benefit. Replacing red or processed meat with mushrooms was associated with even greater longevity benefits. Mushrooms’ beneficial effects likely come from their high antioxidant content, particularly compounds called ergothioneine and glutathione.

Read More »

Clinico-epidemiological evaluation of pharmaceutical/non-pharmaceutical poisoning in a referral poisoning emergency in the Central part of Iran

mycolabadmin

This study examined over 5,700 poisoning cases in Iran to compare outcomes between people poisoned by medications versus other substances like pesticides. Medication poisonings were more common in women and were usually intentional overdoses, while pesticide poisonings were more common in men and often accidental. People poisoned by non-pharmaceutical substances had worse outcomes with a higher death rate. Understanding these differences helps hospitals and communities develop better prevention strategies and treatment approaches.

Read More »

Clinical Challenges and Predictive Risk Factors for Outcomes in COVID-19–Associated Mucormycosis

mycolabadmin

During the COVID-19 pandemic, a dangerous fungal infection called mucormycosis has become a serious complication, especially for patients with uncontrolled diabetes or those taking certain medications. Researchers studied 180 patients with this condition and found that the infection can spread from the sinuses to the eyes and brain, leading to severe outcomes. The most important factors in surviving this infection are early detection, keeping blood sugar controlled, careful use of steroids, and aggressive treatment with antifungal medications and sometimes surgery.

Read More »
Scroll to Top